Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2005-11-30
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A, 1
Placebo 45 minutes prior to surgery
Placebo
100 ml sodium chloride i.v. 45 minutes prior to surgery
A, 2
8 mg Dexamethasone 45 minutes prior to surgery
Dexamethason Helvepharm ®
8 mg Dexamethason i.v. 45 minutes prior to surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethason Helvepharm ®
8 mg Dexamethason i.v. 45 minutes prior to surgery
Placebo
100 ml sodium chloride i.v. 45 minutes prior to surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Chronic pain disorder
* Insulin dependent diabetes mellitus
* History of PONV
* Pregnancy
* Age \< 18 years
* Received antiemetic therapy within 48 hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Visceral- and Transplantation Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephan A. Vorburger, MD
Role: PRINCIPAL_INVESTIGATOR
Dept of visceral- and transplant surgery, University Hospital Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of visceral- and transplant surgery
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Worni M, Schudel HH, Seifert E, Inglin R, Hagemann M, Vorburger SA, Candinas D. Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function. Ann Surg. 2008 Dec;248(6):1060-6. doi: 10.1097/SLA.0b013e31818c709a.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK_49_05
Identifier Type: -
Identifier Source: org_study_id